ArticleBlood advances2019

Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma.

Edward A Stadtmauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.